EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Investigation of in vitro and in vivo therapeutic activity of Tarantula cubensis extract (Theranekron®) on Leishmania major

Siraj Ahmed Khan, Smita Bordoloi, Anisha Shah, Subrata Baidya

Journal of Vector Borne Diseases · 2024

DOI: 10.4103/0972-9062.392268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vector Borne Diseases, 2024. Verfasst von Siraj Ahmed Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical entomology, Arbovirology and Rickettsial Diseases, Indian Council of Medical Research-Regional Medical Research Centre, Dibrugarh…. Hauptthemen laut MEDLINE: Larva, Mosquito Vectors, Aedes, Pupa. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives: Cutaneous leishmaniasis (CL) is a vector-borne parasitic disease caused by several species of the protozoan parasite Leishmania. The need for new anti-leishmanial drugs for the treatment of CL is complicated by factors such as high cost, toxicity, potential for resistance and limited long-term use of existing anti-leishmanial drugs. The aim of this study was to investigate the therapeutic effect of Tarantula cubensis alcoholic extract (TCE), which has been shown to have wound-healing, anti-inflammatory, regenerative, resolving and epithelialising effects, on Leishmania major promastigotes in vitro and in vivo in an experimental mouse model of CL.

Methods

The effect of TCE on L. major promastigotes in vitro was investigated after determining non-cytotoxic concentrations of TCE using the XTT method. To establish a CL model, L. major amastigotes were injected into the paws of BALB/c mice. Lesion size and histopathological evaluation were used to assess the effect of treatment.

Results

TCE was found to be effective against L. major promastigotes at 24 h and 48 h at concentrations 250 μg/ mL, 125 μg/mL and 62.5 μg/mL ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LarvaMosquito VectorsAedesPupaDengueDengue VirusEcosystemAnimalsIndiaHumansFemale

Autor:innen und Institutionen

  • Division of Medical entomology, Arbovirology and Rickettsial Diseases, Indian Council of Medical Research-Regional Medical Research Centre, Dibrugarh, Assam, India.
  • Department of Life Sciences, Dibrugarh University, Dibrugarh, Assam, India.
  • Agartala Government Medical College, Tripura, India.

Zitieren

APA

Khan, S. A., Bordoloi, S., Shah, A., & Baidya, S. (2024). Investigation of in vitro and in vivo therapeutic activity of Tarantula cubensis extract (Theranekron®) on Leishmania major. Journal of Vector Borne Diseases. https://doi.org/10.4103/0972-9062.392268

Vancouver

Khan SA, Bordoloi S, Shah A, Baidya S. Investigation of in vitro and in vivo therapeutic activity of Tarantula cubensis extract (Theranekron®) on Leishmania major. Journal of Vector Borne Diseases. 2024. doi:10.4103/0972-9062.392268

BibTeX
@article{Khan2024,
  author = {Khan, Siraj Ahmed and Bordoloi, Smita and Shah, Anisha and Baidya, Subrata},
  title = {Investigation of in vitro and in vivo therapeutic activity of Tarantula cubensis extract (Theranekron®) on Leishmania major},
  journal = {Journal of Vector Borne Diseases},
  year = {2024},
  doi = {10.4103/0972-9062.392268}
}
Kostenlos starten →